Keigo Chida

11PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 19, 2025
Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of Patients.

Shinpei Ushiyama, Takumi Habu, Izuma Nakayama

|Aug 01, 2025
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological Factors.

Amane Jubashi, Izuma Nakayama, Naoya Sakamoto

|Jun 04, 2024
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.

Akihito Kawazoe, Rui-Hua Xu, Pilar García-Alfonso

|Mar 07, 2022
Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy.

Keigo Chida, Akihito Kawazoe, Toshihiro Suzuki

|Feb 21, 2022
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy.

Yoshiaki Nakamura, Wataru Okamoto, Tadamichi Denda

|Jul 07, 2021
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.

Keigo Chida, Daisuke Kotani, Toshiki Masuishi

Pageof 2

Frequent Collaborators

5 joint publications

Hideaki Bando

5 joint publications

Takayuki Yoshino

4 joint publications

Yoshiaki Nakamura

4 joint publications

Kohei Shitara